Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Alibaba Health Information Technology Ltd. (HK:0241)
HKEX:0241
Holding HK:0241?
Track your performance easily
See the Price Targets and Ratings of:
0241 Analyst Ratings
Currently, no data available
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
0241 Stock 12 Month Forecast
There Are No Analyst Ratings for HK:0241 In The Last 3 Months.
| Highest Price Target― | Average Price Target― | Lowest Price Target― |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
0241 Financial Forecast
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Goldman Sachs
HK$4.4
Buy
54.39%
Upside
Initiated
06/18/24
Alibaba Health resumed with a Buy at Goldman SachsAlibaba Health resumed with a Buy at Goldman Sachs
Macquarie
HK$3.6
Hold
26.32%
Upside
Reiterated
06/07/24
Macquarie Reiterates Neutral Rating on Alibaba Health (241:HK) (BABA)Macquarie analyst John Wang reiterated a Neutral rating and HK$3.60 price target on Alibaba Health (241:HK) (NYSE: BABA).
CLSA
HK$4.1→HK$4.5
Buy
57.89%
Upside
Reiterated
05/29/24
Alibaba Health (241:HK) (BABA) PT Raised to HK$4.50 at CLSACLSA analyst Leo You raised the price target on Alibaba Health (241:HK) (NYSE: BABA) to HK$4.50 (from HK$4.10) while maintaining a Buy (1) rating.
HSBC
HK$4.5→HK$5.5
Buy
92.98%
Upside
Reiterated
05/29/24
Alibaba Health (241:HK) PT Raised to HK$5.50 at HSBCHSBC analyst Charlene Liu raised the price target on Alibaba Health (241:HK) to HK$5.50 (from HK$4.50) while maintaining a Buy rating.
Morgan Stanley
HK$5
Sell
75.44%
Upside
Reiterated
01/05/24
Analysts Offer Insights on Healthcare Companies: Alibaba Health Information Technology (Other OTC: ALBHF) and Insmed (NASDAQ: INSM)
Jefferies
HK$8.2
Buy
187.72%
Upside
Reiterated
12/03/23
Buy Rating Affirmed for Alibaba Health on Strong Financials and Strategic Acquisition
Citi
HK$9.5→HK$8
Buy
180.70%
Upside
Reiterated
12/01/23
Alibaba Health (241:HK) (BABA) PT Lowered to HK$8 at CitiCiti analyst Cui Cui lowered the price target on Alibaba Health (241:HK) (NYSE: BABA) to HK$8.00 (from HK$9.50) while maintaining a Buy rating.
UBS
HK$6.5→HK$5
Hold
75.44%
Upside
Reiterated
10/24/23
Alibaba Health (241:HK) PT Lowered to HK$5 at UBSUBS analyst Henry Liu lowered the price target on Alibaba Health (241:HK) to HK$5.00 (from HK$6.50) while maintaining a Neutral rating.
Best Analysts Covering Alibaba Health Information Technology
Which Analyst Should I Follow If I Want to Buy HK:0241 and Sell After:
1 Month
xxx
Success Rate
1/3 ratings generated profit
Average Return
0.00%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 33.33% of your transactions generating a profit, with an average return of 0.00% per trade.
3 Months
xxx
Success Rate
1/3 ratings generated profit
Average Return
-17.53%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 33.33% of your transactions generating a profit, with an average return of -17.53% per trade.
1 Year
Success Rate
0/3 ratings generated profit
Average Return
-22.57%
reiterated a buy rating 4 months ago
Copying Charlene Liu's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -22.57% per trade.
2 Years
xxx
Success Rate
0/3 ratings generated profit
Average Return
-23.93%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -23.93% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
0241 Analyst Recommendation Trends
Rating
Dec 23
Jan 24
Apr 24
May 24
Jun 24
Strong Buy
3
3
2
3
4
Buy
0
0
0
0
0
Hold
2
1
1
1
2
Sell
0
1
1
1
0
Strong Sell
0
0
0
0
0
total
5
5
4
5
6
Each month's total comprises the sum of three months' worth of ratings.
0241 Stock Forecast FAQ
What is HK:0241’s average 12-month price target, according to analysts?
Currently, no data Available
What is HK:0241’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for HK:0241, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Alibaba Health Information Technology Ltd. a Buy, Sell or Hold?
Currently, no data Available
What is Alibaba Health Information Technology Ltd.’s share price target?
Currently, no data Available
What do analysts say about Alibaba Health Information Technology Ltd.?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of Alibaba Health Information Technology Ltd.?
To buy shares of HK:0241, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.